sentences.id: IEPA.d27.s57
sentences.origID: 485
sentences.text: 8-OH-DPAT also increased insulin and decreased CCK and somatostatin levels, effects that were blocked by pretreatment with the oxytocin antagonist
sentences.id: IEPA.d27.s57.e0
sentences.origID: 1092
sentences.text: insulin
sentences.id: IEPA.d27.s57.e1
sentences.origID: 1093
sentences.text: oxytocin
sentences.id: IEPA.d27.s57.i0
sentences.e1: IEPA.d27.s57.e0
sentences.e2: IEPA.d27.s57.e1
sentences.type: PPI
sentences.id: IEPA.d27.s58
sentences.origID: 486
sentences.text: Taken together, these data suggest that the effect of 8-OH-DPAT on plasma levels of insulin, somatostatin and CCK may be mediated by oxytocin
sentences.id: IEPA.d27.s58.e0
sentences.origID: 1094
sentences.text: insulin
sentences.id: IEPA.d27.s58.e1
sentences.origID: 1095
sentences.text: oxytocin
sentences.id: IEPA.d27.s58.i0
sentences.e1: IEPA.d27.s58.e0
sentences.e2: IEPA.d27.s58.e1
sentences.type: PPI
sentences.id: IEPA.d27.s59
sentences.origID: 487
sentences.text: In previous experiments, we have shown that following i.c.v. application of oxytocin, plasma levels of insulin are increased through a cholinergic mechanism
sentences.id: IEPA.d27.s59.e0
sentences.origID: 1096
sentences.text: oxytocin
sentences.id: IEPA.d27.s59.e1
sentences.origID: 1097
sentences.text: insulin
sentences.id: IEPA.d27.s59.i0
sentences.e1: IEPA.d27.s59.e0
sentences.e2: IEPA.d27.s59.e1
sentences.type: PPI